Address
304 North Cardinal
St. Dorchester Center, MA 02124
Work Hours
Monday to Friday: 7AM - 7PM
Weekend: 10AM - 5PM
Address
304 North Cardinal
St. Dorchester Center, MA 02124
Work Hours
Monday to Friday: 7AM - 7PM
Weekend: 10AM - 5PM
learn more about what peptides actually are, what they can be used for, and how to use them.
For research and educational purposes only. All compounds discussed on AethonLabs.ca are sold strictly for research use and are not intended for human consumption. Always consult a qualified healthcare professional before beginning any new protocol.
Last updated: July 2026
If you’ve landed here, you’ve probably been hearing about peptides everywhere lately — in fitness groups, on a podcast, maybe from a friend who dropped thirty pounds and won’t stop talking about it. And now you’re wondering what these actually are, whether any of it is legitimate, and where you’d even start.
We get it. This space assumes a lot of background knowledge nobody hands you upfront — you’re supposed to already know what a GLP-1 receptor is, or why a Certificate of Analysis matters, or how to tell a real research finding from a confident-sounding fabrication. Nobody wrote the guide we actually needed when we started. This is that guide, and it’s built to do two things: give you an honest orientation to this entire space, and leave you with the actual skills to navigate the rest of this site — and this space generally — more capably than most people who’ve already run their first protocol.
At the most basic level, a peptide is a short chain of amino acids — the same building blocks that make up every protein in your body and your food. The only real difference between a peptide and a protein is size: proteins are long chains, sometimes thousands of amino acids long; peptides are short, typically somewhere between 2 and 50.
Your body is making peptides constantly, right now, without you thinking about it. Insulin is a peptide. So is the hormone that tells your brain you’re full after a meal. Peptides are essentially messenger molecules — they travel through your body and tell cells to do specific things: grow, repair, release a hormone, slow digestion, burn fat.
The peptides discussed across this site are either identical to ones your body already makes, or engineered to mimic those natural signals in a more targeted, potent, or longer-lasting way. That’s the whole appeal, and it’s a real one: unlike a lot of traditional pharmaceuticals, which tend to work by broadly flooding or blocking a system, a well-designed peptide can activate one specific receptor and trigger one specific response, with comparatively limited effects on everything else.
Peptides aren’t new — researchers have been studying this class of compound for decades. What’s new is how fast the word itself went mainstream, and Canadians have had a front-row seat to that shift in a very specific way: through Health Canada’s own escalating public response to it.
Starting in 2025, Health Canada issued a series of increasingly specific advisories about unauthorized injectable peptides, culminating in an April 2026 advisory naming a long list of compounds directly and warning that “for research use only” labeling doesn’t change their underlying legal status. A CBC News investigation the following week found that several of the named products were still easily purchased online with Canadian shipping — a genuinely useful, honest snapshot of where enforcement actually stands versus where policy says it should. Our dedicated Canadian regulatory guide covers all of this in far more depth, including what’s actually legal to possess versus sell, and what changed specifically in 2026.
The broader “why now” story traces back to the GLP-1 boom. When semaglutide (Ozempic, Wegovy) became a household name and people saw a once-weekly injection producing serious, sustained weight loss, curiosity about the wider peptide category exploded almost immediately — if this works, people reasoned, what else is out there? Public figures discussing compounds like BPC-157 for injury recovery accelerated that curiosity further, and by early 2026, global search interest in the general term “peptides” had climbed to roughly the same level as “Ozempic” itself.
Regulatory tightening elsewhere had, if anything, the opposite of its intended effect. When the FDA restricted a large group of popular research peptides in late 2023, cutting off a licensed compounding-pharmacy pathway many people had been using, the effect wasn’t reduced interest — it was demand moving somewhere less regulated, not more. That’s a useful pattern to keep in mind generally: restricting an accessible, verifiable channel doesn’t reduce curiosity, it just changes where people go looking, often somewhere with less oversight, not more.
Before you read a single compound guide, this is the one skill worth having. Every guide on this site is built around being honest about evidence quality — not just “does this work,” but “how do we actually know that, and how confident should we really be.” Learning to ask that question yourself is what separates a careful researcher from someone who got lucky.
Not all evidence is the same kind of evidence. Roughly in order of how much confidence they deserve: a completed, published, well-designed human clinical trial that actually tested the outcome you care about; a real, credible human trial that measured something different than what you’re actually interested in; a completed trial that failed to show the intended effect (which is still real information, not nothing); animal or cell-culture research suggesting a mechanism is plausible; and community-reported experience, which is genuinely useful for understanding what a protocol actually feels like, but isn’t a substitute for any of the categories above it. A recurring pattern across this entire site: several widely-used compounds have extensive, legitimate animal research and almost no completed human trials for the reason people actually use them today. That’s not automatically a reason to avoid a compound — it’s a reason to know exactly what you’re actually relying on when you decide to research it.
Specific-sounding claims deserve specific scrutiny, not automatic trust. A named journal, an exact statistic, a described case report — all of that reads as credible, and sometimes it is. But while building this site’s own guides, we’ve directly encountered fabricated statistics, invented case reports, and phantom clinical trials, presented with exactly this kind of false precision, circulating across multiple peptide information sites. The habit worth building: if a claim is specific enough to check, actually check it — search for the study directly, see if it’s independently corroborated by more than one source, and treat a claim that only exists on marketing-style content as unverified, not as fact with a citation attached.
Popularity and evidence are two completely different signals. A compound being widely discussed, heavily marketed, or available at thousands of clinics tells you about demand, not about what’s been proven. Some of the most commercially popular compounds in this space have the thinnest completed human evidence behind their specific marketed claims — that gap is worth knowing about upfront, not discovering after the fact.
Where this actually gets used: every individual compound guide on this site has a “What the Research Shows” section written with exactly this framework — what’s actually been demonstrated, in what form, for what population, versus what’s simply plausible or popular. Reading those sections critically, rather than skimming for a reassuring conclusion, is the entire payoff of this section.
Once you understand how to weigh evidence, the rest of this is about building real operational competence — in a specific, deliberate order, since each stage depends on the one before it.
This is the single highest-stakes decision in the entire process, and it comes before anything else for a reason: a compound’s evidence profile doesn’t matter at all if what’s actually in the vial isn’t what the label claims. Our full guide on reading a Certificate of Analysis and vetting a vendor walks through exactly how to verify a COA against the issuing lab’s own public records in under five minutes — a habit worth building before you place a single order, not after your first shipment arrives.
Once you know how to source responsibly, the next stage is the mechanical side — in this specific order, since each step builds on the last:
Our dose math guide teaches the underlying concepts — what a milligram, millilitre, and syringe unit actually are, and how to calculate any dose from any concentration yourself — rather than just handing you a table of numbers to look up. Once this genuinely makes sense, you can work out a dose for literally any compound on this site without needing to memorize anything compound-specific in advance.
With the foundational skills above in place, this is where you start making real compound-specific decisions. Rather than pointing you at one compound per category, we’d point you toward the comparison guide for whichever category matches your objective — Metabolic, Regenerative, Growth Hormone Axis, Longevity, or Cognitive — since seeing the real options compared side by side, with the evidence-literacy framework you now have, is a far better starting point than picking a name you’ve simply heard the most.
Nobody tells beginners this upfront, so here’s a straightforward version. Costs vary by compound and vendor, but as a general shape: a single vial from a reputable, COA-verified vendor typically runs somewhere in the range of $40–150 CAD depending on the compound and dose, lasting anywhere from two to six weeks depending on your protocol. Add modest, genuinely inexpensive recurring costs — BAC water, syringes, alcohol swabs, a sharps container — that together add relatively little on top of the compound cost itself. The real budgeting mistake isn’t underestimating any single cost; it’s not accounting for the fact that a serious protocol is an ongoing monthly expense, not a one-time purchase, and deciding upfront whether that’s sustainable for you is worth doing before your first order rather than three months in.
Worth knowing before you start, since expectations shape how a protocol actually feels.
Week one is mostly logistics, not results. Getting your supplies, reconstituting correctly, working out your first dose calculation, and simply building the habit of a consistent routine. For most compounds, this week won’t feel like much of anything yet, and that’s normal, not a sign something’s wrong.
Early side effects, where they occur, cluster in the first few weeks and often ease with time. This is a genuinely consistent pattern across very different compound categories — titration exists specifically to manage this, and rushing it is one of the most common, most avoidable mistakes covered throughout this site.
Track from day one, even loosely. Dose, date, and anything you notice. Three weeks in, you will not reliably remember your exact reconstitution volume or when a symptom actually started — a habit this simple is what turns a vague impression into something you can actually act on.
Plateaus and quiet weeks are normal, not failure. Several compounds on this site show genuinely non-linear results in both trial data and community report — a flat week doesn’t necessarily mean nothing is happening.
Is this all just an unregulated fad? No — some of what’s discussed in this space is genuinely Health Canada and FDA-approved medicine, some is off-label use of those same approved drugs, and some is unapproved research compounds with a real but earlier-stage evidence base. Treating all three tiers as equivalent, in either direction, is one of the most common mistakes beginners make.
Do I need a prescription for any of this? For the approved pharmaceutical versions of compounds like semaglutide, yes. For research-grade compounds sold outside that pharmacy channel, no prescription is involved — which also means none of the oversight that comes with one, and exactly why sourcing verification matters as much as it does.
How do I know which compound is actually right for me? Start from your objective, not from a compound name you’ve heard. The category comparison guides are built specifically to help you match an objective to the right research area, rather than the other way around.
Is it safe to combine multiple compounds? Sometimes there’s a real, mechanistically sound reason to, and sometimes it’s just added complexity without a clear rationale. Understand each compound individually first, and check whether a specific combination has a documented rationale behind it rather than assuming more is always better.
Where should someone brand new actually start reading? Right here, first — then the foundational skills in order (sourcing, supplies, reconstitution, storage, injection, dose math), then whichever category comparison matches your actual objective.
The more of this landscape you actually understand, the better decisions you’ll make from here. That’s the entire point of this resource.
This guide reflects the peptide research landscape as of publication and will be updated periodically as it evolves. It is provided for research and educational purposes only and does not constitute medical advice. AethonLabs.ca sells all compounds strictly for research use; products are not intended for human consumption. Consult a qualified healthcare professional before beginning any new protocol.
AETHON LABS — Tested. Documented. Delivered.